{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:22:36Z","timestamp":1724372556570},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,21]]},"DOI":"10.7759\/cureus.67444","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T05:05:35Z","timestamp":1724303135000},"source":"Crossref","is-referenced-by-count":0,"title":["Curative Surgery After Neoadjuvant Chemotherapy for Locally Advanced Sigmoid Colon Cancer With Extensive Abdominal Wall Invasion: A Case Report"],"prefix":"10.7759","author":[{"given":"Hirofumi","family":"Suzumura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Terauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seigo","family":"Yukisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Kimata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroharu","family":"Shinozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7417\/CT.2013.1605","article-title":"Abdominal wall reconstruction after resection of an enterocutaneous fistula with an island pedicled anterolateral thigh perforator flap. Case report","volume":"164","author":"Ali F","year":"2013","unstructured":"Ali F, Safawi EB, Zakaria Z, Basiron N. Abdominal wall reconstruction after resection of an enterocutaneous fistula with an island pedicled anterolateral thigh perforator flap. Case report. Clin Ter. 2013, 164:413-5. 10.7417\/CT.2013.1605","journal-title":"Clin Ter"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.0355","article-title":"Three versus 6 months of oxaliplatin-based adjuvant chemotherapy for patients with stage III colon cancer: Disease-free survival results from a randomized, open-label, International Duration Evaluation of Adjuvant (IDEA) France, phase III trial","volume":"36","author":"Andr\u00e9 T","year":"2018","unstructured":"Andr\u00e9 T, Vernerey D, Mineur L, et al.. Three versus 6 months of oxaliplatin-based adjuvant chemotherapy for patients with stage III colon cancer: Disease-free survival results from a randomized, open-label, International Duration Evaluation of Adjuvant (IDEA) France, phase III trial. J Clin Oncol. 2018, 36:1469-77. 10.1200\/JCO.2017.76.0355","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70227-X","article-title":"Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC- 8): An open-label, randomised phase III trial","volume":"15","author":"Taieb J","year":"2014","unstructured":"Taieb J, Tabernero J, Mini E, et al.. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC- 8): An open-label, randomised phase III trial. Lancet Oncol. 2014, 15:862-73. 10.1016\/S1470-2045(14)70227-X","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.8.583","article-title":"Guidelines 2000 for colon and rectal cancer surgery","volume":"93","author":"Nelson H","year":"2001","unstructured":"Nelson H, Petrelli N, Carlin A, et al.. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2001, 93:583-96. 10.1093\/jnci\/93.8.583","journal-title":"J Natl Cancer Inst"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham D","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, et al.. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006, 355:11-20. 10.1056\/NEJMoa055531","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn E","year":"2001","unstructured":"Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001, 345:638-46. 10.1056\/NEJMoa010580","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70348-0","article-title":"Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial","volume":"13","author":"Foxtrot Collaborative Group","year":"2012","unstructured":"Foxtrot Collaborative Group. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol. 2012, 13:1152-60. 10.1016\/S1470-2045(12)70348-0","journal-title":"Lancet Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2078-6891.2014.006","article-title":"Tumor response assessment in locally advanced colon cancer after neoadjuvant chemotherapy","volume":"5","author":"Arredondo J","year":"2014","unstructured":"Arredondo J, Gonz\u00e1lez I, Baixauli J, et al.. Tumor response assessment in locally advanced colon cancer after neoadjuvant chemotherapy. J Gastrointest Oncol. 2014, 5:104-11. 10.3978\/j.issn.2078-6891.2014.006","journal-title":"J Gastrointest Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2015.1037007","article-title":"Neoadjuvant chemotherapy in locally advanced colon cancer. A phase II trial","volume":"54","author":"Jakobsen A","year":"2015","unstructured":"Jakobsen A, Andersen F, Fischer A, et al.. Neoadjuvant chemotherapy in locally advanced colon cancer. A phase II trial. Acta Oncol. 2015, 54:1747-53. 10.3109\/0284186X.2015.1037007","journal-title":"Acta Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08651-8","article-title":"Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial","volume":"359","author":"Medical Research Council Oesophageal Cancer Working Group","year":"2002","unstructured":"Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial. Lancet. 2002, 359:1727-33. 10.1016\/S0140-6736(02)08651-8","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000003454","article-title":"Perioperative FOLFOX 4 versus FOLFOX 4 plus cetuximab versus immediate surgery for high-risk stage II and III colon cancers: A phase II multicenter randomized controlled trial (PRODIGE 22)","volume":"271","author":"Karoui M","year":"2020","unstructured":"Karoui M, Rullier A, Piessen G, et al.. Perioperative FOLFOX 4 versus FOLFOX 4 plus cetuximab versus immediate surgery for high-risk stage II and III colon cancers: A phase II multicenter randomized controlled trial (PRODIGE 22). Ann Surg. 2020, 271:637-45. 10.1097\/SLA.0000000000003454","journal-title":"Ann Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.21037\/jgo-20-220","article-title":"Neoadjuvant therapy in locally advanced colon cancer: A meta-analysis and systematic review","volume":"11","author":"Cheong CK","year":"2020","unstructured":"Cheong CK, Nistala KR, Ng CH, et al.. Neoadjuvant therapy in locally advanced colon cancer: A meta-analysis and systematic review. J Gastrointest Oncol. 2020, 11:847-57. 10.21037\/jgo-20-220","journal-title":"J Gastrointest Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(86)92612-7","article-title":"Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: Histopathological study of lateral tumour spread and surgical excision","volume":"328","author":"Quirke P","year":"1986","unstructured":"Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986, 328:996-9. 10.1016\/s0140-6736(86)92612-7","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-017-3566-z","article-title":"Neoadjuvant chemotherapy improves survival in patients with clinical T4b colon cancer","volume":"22","author":"Dehal A","year":"2018","unstructured":"Dehal A, Graff-Baker AN, Vuong B, et al.. Neoadjuvant chemotherapy improves survival in patients with clinical T4b colon cancer. J Gastrointest Surg. 2018, 22:242-9. 10.1007\/s11605-017-3566-z","journal-title":"J Gastrointest Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61087-3","article-title":"Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): A randomised controlled trial","volume":"370","author":"Seymour MT","year":"2007","unstructured":"Seymour MT, Maughan TS, Ledermann JA, et al.. Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): A randomised controlled trial. Lancet. 2007, 370:143-52. 10.1016\/S0140-6736(07)61087-3","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.4860","article-title":"Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: The PRIME study","volume":"28","author":"Douillard JY","year":"2010","unstructured":"Douillard JY, Siena S, Cassidy J, et al.. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: The PRIME study. J Clin Oncol. 2010, 28:4697-705. 10.1200\/JCO.2009.27.4860","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyt115","article-title":"Neoadjuvant oxaliplatin and capecitabine and bevacizumab without radiotherapy for poor-risk rectal cancer: N-SOG 03 Phase II trial","volume":"43","author":"Uehara K","year":"2013","unstructured":"Uehara K, Hiramatsu K, Maeda A, et al.. Neoadjuvant oxaliplatin and capecitabine and bevacizumab without radiotherapy for poor-risk rectal cancer: N-SOG 03 Phase II trial. Jpn J Clin Oncol. 2013, 43:964-71. 10.1093\/jjco\/hyt115","journal-title":"Jpn J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70509-0","article-title":"Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): A phase 3 randomised controlled trial","volume":"13","author":"de Gramont A","year":"2012","unstructured":"de Gramont A, Van Cutsem E, Schmoll HJ, et al.. Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): A phase 3 randomised controlled trial. Lancet Oncol. 2012, 13:1225-33. 10.1016\/S1470-2045(12)70509-0","journal-title":"Lancet Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/0007-1226(84)90002-x","article-title":"The free thigh flap: A new free flap concept based on the septocutaneous artery","volume":"37","author":"Song YG","year":"1984","unstructured":"Song YG, Chen GZ, Song YL. The free thigh flap: A new free flap concept based on the septocutaneous artery. Br J Plast Surg. 1984, 37:149-59. 10.1016\/0007-1226(84)90002-x","journal-title":"Br J Plast Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/00006534-200206000-00007","article-title":"Have we found an ideal soft-tissue flap? An experience with 672 anterolateral thigh flaps","volume":"109","author":"Wei FC","year":"2002","unstructured":"Wei FC, Jain V, Celik N, Chen HC, Chuang DC, Lin CH. Have we found an ideal soft-tissue flap? An experience with 672 anterolateral thigh flaps. Plast Reconstr Surg. 2002, 109:2219-26. 10.1097\/00006534-200206000-00007","journal-title":"Plast Reconstr Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/281845-curative-surgery-after-neoadjuvant-chemotherapy-for-locally-advanced-sigmoid-colon-cancer-with-extensive-abdominal-wall-invasion-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T05:05:41Z","timestamp":1724303141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/281845-curative-surgery-after-neoadjuvant-chemotherapy-for-locally-advanced-sigmoid-colon-cancer-with-extensive-abdominal-wall-invasion-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.67444","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,21]]}}}